Jung Wook Park

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Manish A. Shah, Kohei Shitara, Jaffer A. Ajani et al. · Nature Medicine · 2023 · 450 citations · Full text

Esophageal Cancer, Glow Trial, Cancer Management +16

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

John K. Lee, John W. Phillips, B. Smith et al. · Cancer Cell · 2016 · 408 citations · Full text

Urology, Genitourinary Cancer, Medicine +6

Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage

Jung Wook Park, John K. Lee, Katherine M. Sheu et al. · Science · 2018 · 353 citations · Full text

Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies

Nikolas G. Balanis, Katherine M. Sheu, Favour N. Esedebe et al. · Cancer Cell · 2019 · 179 citations · Full text

Pancreatic Cancer, Malignant Disease, Medicine +12

Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer

John K. Lee, Nathanael J. Bangayan, Timothy Chai et al. · Proceedings of the National Academy of Sciences · 2018 · 151 citations · Full text

Immunology, Immunoediting, Pathology +17